Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia
Status:
Recruiting
Trial end date:
2022-01-11
Target enrollment:
Participant gender:
Summary
This is an open label, eight week, clinical trial of a proprietary high CBD/low THC
sublingual solution for the treatment of clinically significant anxiety and agitation in mild
to moderate Alzheimer's Disease.